Pub. Date : 2017 Oct-Dec
PMID : 29276624
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Objective: The objective of this paper is to assess the effect of IFN beta-1a and placebo on CBH evolution and disability in patients with relapsing-remitting multiple sclerosis (RRMS), as well as CBH evolution in patients with secondary progressive multiple sclerosis (SPMS). | S-(D-CARBOXYBUTYL)-L-HOMOCYSTEINE | interferon alpha 1 | Homo sapiens |
2 | Results: In RRMS patients, the risk of >=1 evolved CBH was lower for IFN beta-1a versus placebo (odds ratio 0.42; p = 0.024); volume of newly evolved CBH was numerically reduced. | S-(D-CARBOXYBUTYL)-L-HOMOCYSTEINE | interferon alpha 1 | Homo sapiens |
3 | Conclusion: In RRMS, IFN beta-1a significantly decreased the proportion of new T1 Gd+ lesions evolving into CBH and the risk of developing a CBH. | S-(D-CARBOXYBUTYL)-L-HOMOCYSTEINE | interferon beta 1 | Homo sapiens |
4 | Conclusion: In RRMS, IFN beta-1a significantly decreased the proportion of new T1 Gd+ lesions evolving into CBH and the risk of developing a CBH. | S-(D-CARBOXYBUTYL)-L-HOMOCYSTEINE | interferon beta 1 | Homo sapiens |